Estudos realizados na última década mostram que a substância P (SP) é um neuromediador importante de estados emocionais e afetivos. A SP tem ação pró-aversiva quando microinjetada na substância cinzenta periaquedutal dorsal (SCPd) através da ativação de receptores neurocininérgicos do tipo NK-1, uma vez que o comportamento defensivo é bloqueado por antagonistas desses receptores. A ativação de receptores NK-1 na SCPd também produz antinocicepção, a qual é considerada parte da reação de defesa. Na sequência desses estudos, este projeto visa investigar o envolvimento dos receptores neurocininérgicos no núcleo central (CeA) e basolateral (BLA) da amígdala na mediação dos estados aversivos gerados e elaborados nessa estrutura prosencefálica que, junto com a SCPd, faz parte do sistema encefálico aversivo. O presente estudo mostrou que a SP e o agonista NK-1 (Sar-Met-SP) promoveram efeitos pró-aversivos no labirinto em cruz elevado somente no CeA, mas não no BLA. Ao contrário da SCPd, não obtivemos qualquer alteração no limiar nociceptivo com a microinjeção de antagonista de receptores NK-1 (Spantide) em ambos os núcleos. O Spantide sozinho não alterou os indicadores de nocicepção e ansiedade. Nenhum tipo de vocalização (audível ou ultrassônica) foi detectado no presente trabalho após a microinjeção de SP ou Sar-Met-SP em ambos núcleos amigdalóides, apesar de relatos de vocalizações ultrassônicas (VUS) após o mesmo tipo de tratamento na SCPd. Os resultados obtidos no presente estudo mostraram que o CeA, mas não o BLA, modula a expressão de comportamentos relacionados ao medo inato através de receptores neurocininérgicos do tipo NK-1. VUS e antinocicepção não parecem participar da reação de defesa elaborada no CeA. A ausência da emissão de VUS nesses núcleos pode indicar que somente estruturas mais antigas do neuroeixo (mesencéfalo e hipotálamo) são responsáveis pela produção de VUS. / A substantial body of evidence obtained in the last decade demonstrated that the Substance P (SP) is an important mediator of the affective and emotional behaviors. SP is a pro-aversive compound when microinjected within the dorsal periaqueductal gray (dPAG). These effects are mediated by the type 1 neurokininergic receptors (NK-1), since the defensive behavior was inhibited by antagonists of these receptors. The activation of NK-1 receptors in the dPAG also produced antinociception and ultrasonic vocalizations (USV). In the sequence of these studies, this study investigated the involvement of neurokinin receptors of the central (CeA) and basolateral (BLA) nuclei of the amygdala in the mediation of the defense reaction. The amigdala together with the dPAG and the medial hypothalamus comprise the encephalic aversive system. The results showed that SP and the NK-1 agonist (Sar-Met-SP) promoted pro-aversive effects in the elevated plus maze test only when microinjected into the CeA, without effect in the BLA. Although SP and the activation of NK-1 receptors induce antinociception in the dPAG, we did not observe any alteration of the nociceptive threshold in the tail-flick test with the NK-1 antagonist (Spantide) injected into both nuclei and any changes of the anxiety parameters in the EPM. No vocalizations (audible or ultrasonic) were detected after treatment with SP or Sar-Met-SP in both amygdaloid nuclei. The lack of emissions of USVs after activation of these nuclei could indicate that only older structures (PAG and hypothalamus) of the neuroaxis are responsible for the production of USVs. The results obtained in the present study show that NK-1 receptors within CeA, but not BLA, modulate the expression of defensive behaviors related to the innate fear. Apparentely USVs and antinociception are not involved in the defensive reactions indiced by activation of NK-1 mechanisms in the CeA.

O efeito ansiolítico dos benzodiazepínicos (BZDs) é reduzido depois da primeira exposição ao labirinto em cruz elevado (LCE). Várias hipóteses tem sido formuladas para explicar este fenômeno chamado one-trial tolerance (OTT), entretanto, nenhuma delas é conclusiva. No presente estudo, examinamos este fenômeno através da análise etofarmacológica de ratos submetidos ao LCE em duas sessões (T1 e T2), e do conteúdo de monoaminas presentes no córtex pré-frontal, amígdala, hipocampo e núcleo accumbens através da técnica de Cromatografia Líquida de Alta Pressão. Ratos machos Wistar foram tratados com salina ou midazolam (0,5 mg/Kg, i.p.) antes de T1 e T2 e imediatamente depois, seus encéfalos foram dissecados e as estruturas analisadas. Como controle à análise neuroquímica foram incluídos animais tratados com salina e não expostos ao LCE. A administração de midazolam antes de T1 promoveu efeito ansiolítico, aumentando a exploração dos braços abertos, porcentagem de entradas e tempo de permanência nos mesmos. Em T2 foi observado redução da exploração dos braços abertos em relação a T1. Esses resultados sugerem que há uma mudança no estado emocional do animal em T2, que é resistente a ação ansiolítica dos BZDs. Com relação aos resultados dos estudos neuroquímicos, foi observado redução dos conteúdos de serotonina (5- HT) e noradrenalina (NA) no córtex pré-frontal, na amígdala, no hipocampo e no núcleo accumbens depois de T1 e T2. Houve também, redução do conteúdo de dopamina (DA) na amígdala depois de ambas sessões. Não ocorreram mudanças nas taxas de renovação dessas monoaminas em nenhuma das estruturas analisadas. Através desses resultados, pode-se inferir que a estimulação aversiva do LCE causa alterações na neurotransmissão monoaminérgica da amígdala, como também das outras estruturas límbicas estudadas neste trabalho. Essas alterações neuroquímicas depois da primeira exposição ao LCE, devem representar alterações adaptativas na neurotransmissão do sistema límbico que podem estar associadas ao fenômeno da OTT. / Numerous reports have demonstrated that a single exposure to a variety of stressful experiences enhances fearful reactions when behavior is subsequently tested in current animal models of anxiety. Until now, no study has examined the neurochemical changes during the test and retest sessions of freely-behaving rats in the elevated plus-maze (EPM), one of the most traditional tests of anxiety. This work is a new approach looking at the changes in dopamine (DA), serotonin (5-HT) and noradrenaline (NA) levels in the prefrontal cortex, amygdala, hippocampus and nucleus accumbens during one-trial learning development. We used high pressure liquid chromatography to assess the concentrations of these neurotransmitters and their metabolites in animals injected with saline or midazolam upon single or double exposure to the EPM. For the biochemical analysis an extra control group treated with saline and not exposed to EPM was added. The data showed that stressful stimuli present in the maze were able to elicit one-trial learning to midazolam on re-exposure. Significant decreases in 5-HT and NA contents in the prefrontal cortex, amygdala, hippocampus and nucleus accumbens occurred in saline and midazolam injected animals submitted to the first and second trials. Significant decreases in DA content were also observed in the amygdala after both trials. There was no change in the turnover of these monoamines in any structure studied. It is suggested that aversive stimuli inherent to the EPM cause primary changes in the neurochemical mechanisms of the amygdala and also influence the activity of monoaminergic neurotransmission in the prefrontal cortex, hippocampus and nucleus accumbens. The observed reduction in monoaminergic transmission in limbic structures after the first stressful experience in the EPM seems to represent adaptive changes and may be associated to the phenomenon of ?one-trial tolerance?.

La 3,4-metilendioximetanfetamina (MDMA), una sustancia popularmente conocida como éxtasis, es una droga ilícita consumida habitualmente por adolescentes y adultos jóvenes. Además, el policonsumo es una práctica habitual entre los usuarios de la MDMA, siendo la cocaína una de las drogas más frecuentemente asociadas a esta sustancia. El objetivo del presente trabajo fue evaluar los efectos a corto y largo plazo que se producen tras la administración de la MDMA (5, 10, o 20 mg/kg) sola o en combinación con cocaína (25 mg/kg) en ratones adolescentes. En el estudio sobre el efecto agudo, observamos que ambas drogas administradas individual o simultáneamente incrementan la actividad motora. La dosis alta de MDMA disminuye de los contactos sociales en la prueba de la interacción social afectando igualmente el test de retención de la evitación pasiva. Sin embargo, sólo la co-administración de MDMA en combinación con cocaína produjo un efecto ansiolítico caracterizado por un aumento del tiempo de permanencia en los brazos abiertos del laberinto elevado en cruz. Igualmente, el análisis neuroquímico reveló que los ratones que recibieron MDMA en combinación con cocaína mostraron un incremento en el turnover de DA en el estriado, pero una disminución del de serotonina en la corteza. Los estudios de los efectos a largo plazo, realizados tres semanas después de haber finalizado un tratamiento con MDMA sola o en combinación con cocaína (2 administraciones por día durante 3 días consecutivos), mostraron que los ratones expuestos a la MDMA, sola o más cocaína, incrementaron el tiempo dedicado a las conductas sociales, aunque los que también habían recibido cocaína presentaban además conductas de amenaza. Observamos un efecto neurotóxico en los ratones tratados únicamente con 20 mg/kg de MDMA que mostraron un decremento de la concentración de DA en el estriado, no observándose este deterioro en los tratados además con cocaína. Por otra parte, mediante el condicionamiento de la preferencia de lugar (CPL) confirmamos que la MDMA posee efectos reforzantes y que esta sustancia es capaz de reinstaurar la preferencia de lugar una vez que esta se ha extinguido. La expresión y la reinstauración del CPL inducido por la MDMA dependen de la pauta de condicionamiento que condiciona los efectos neurotóxicos producidos por esta droga. Para finalizar, el tratamiento con MDMA sola o en combinación con cocaína durante la adolescencia favorece los efectos reforzantes de la MDMA durante el periodo adulto. Además, la exposición previa a la cocaína aumenta el tiempo necesario para extinguir la preferencia de lugar inducida por la MDMA. / 3,4-methylene-dioxy-methamphetamine (MDMA), commonly known as ecstasy, is an illicit recreational drug consumed by teenagers and young adults. The poly-drug pattern is the most common among those observed in MDMA users, with cocaine being a frequently associated drug. The aim of the present study was to evaluate the short- and long-term effects of exposure to MDMA (5, 10, or 20 mg/kg), alone or plus cocaine (25 mg/kg), on adolescent mice. In the acute phase, both drugs produced hyperactivity whether administered alone or concurrently. The highest MDMA dose decreased social contacts and affected the passive avoidance task. However, an anxiolytic effect, studied by means of the elevated plus maze and expressed as an increase in the time spent on the open arms, was observed only in animals treated with both cocaine and MDMA. Neurochemical analyses revealed an increase in striatal DA turnover and a decrease in serotonin cortical turnover in mice treated with MDMA plus cocaine. The studies conducted to establish long-term effects, which were performed 3 weeks after a 3-day treatment of two daily injections of MDMA alone or plus cocaine (6 administrations) during the adolescent period, showed that mice treated with MDMA alone and plus cocaine spent more time engaged in social contact, although those also treated with cocaine exhibited threat behaviors. Furthermore, we observed a neurotoxic effect in mice exposed to 20 mg/kg of MDMA, evident in a decrease in DA levels in the striatum, but this effect was not detected in mice additionally treated with cocaine. On the other hand, using the conditioned place preference (CPP), we have confirmed the rewarding effects of MDMA. In addition, we also show that MDMA can produce reinstatement of place preference after the extinction of this response. The expression and reinstatement of MDMA-induced CPP depend on the conditioning protocol, which conditions the neurotoxic effects produced by this drug. Finally, exposure during adolescence to MDMA alone or plus cocaine facilitates the rewarding effects of MDMA in adulthood. Moreover, previous experience of cocaine increases the time required to extinguish the MDMA-induced CPP.

Made available in DSpace on 2016-06-02T19:22:05Z (GMT). No. of bitstreams: 1 3116.pdf: 11974848 bytes, checksum: d69698c04f669985473e9e441c532444 (MD5) Previous issue date: 2009-12-11 / Universidade Federal de Sao Carlos / In innate or learned threatening situations, animals display a set of defensive behaviors specie-specific such as autonomic alterations, flight, fight and antinociception. Exposure of mice to open elevated plus-maze (oEPM: four open arms), an aversive situation, elicits antinociception of high magnitude. However, mechanisms involved in this kind of antinociception are not clear yet. This study investigated whether antinociception induced by exposure to an oEPM shows cross-tolerance with morphine (Exp. I and II); is attenuated by repetead exposure to the oEPM (Exp. III); is blocked by systemic treatment with naltrexone (Exp. IV); is prevented by adrenalectomy (Exp. V); persists after animal removal from the oEPM and if there are sex-related differences in this factor (Exp. VI); is mediated by CB1 cannabinoid receptor (Exp. VII). Rats were daily treated with morphine (M, 5 mg/kg, i.p.) or distilled water (DW) for 5 consecutive days (antinociceptive tolerance assessed by the tailflick test). Next day, rats received formalin 2.5% injection (50 μL) into the right hind paw and, after first phase of formalin test, they were treated with M or DW. 25 minutes after formalin injection into the paw, time spent licking the injected paw was recorded for 10 minutes (Exp. 1). Similar procedure was followed in the Experiment II, except that time spent licking the paw was recorded during exposure to the oEPM or enclosed EPM (eEPM: four arms enclosed) in undrugged rats. In Experiment III, nociception was evaluated in rats submitted to 1, 2, 3, 4 or 6 exposures to either eEPM or oEPM (formalin was injected only during the last exposure). Experiment IV investigated the effects of naltrexone (0 and 2.5 mg/kg; s.c.) on nociception during eEPM or oEPM exposure. Nociception was also assessed during the eEPM or oEPM exposure in sham and adrenalectomized rats (exp. V). In experiment VII, rats were treated with vehicle (DMSO 60%) or AM251 (1 mg/kg, i.p., CB1 receptor antagonist). Fifteen minutes later, animals received formalin injection into the paw and, 25 minutes after, they were exposed to the eEPM or oEPM. In experiment VI, male and female rats were exposed to eEPM or oEPM (with no noxious stimulus during exposure) and imediately after they were tested on the hot plate test (52.4 °C). Results showed that antinociception induced by oEPM does not display cross-tolerance to morphine; was not altered for at least 6 exposures to the maze; failed to be reversed by naltrexone; was not prevented by adrenalectomy and was not blocked by AM251. In addition, this antinociception does not persist after animal removal of the apparatus, by contrast, it occurs a hyperalgesia (as assessed by hot plate test), a response that does not depend on sex-related differences. Results suggest that antinociception induced by oEPM: is not mediated by opioid system or CB1 cannabinoid receptors and it is not sensitive to corticosterone. Furthermore, animal removal of aversive environment alters nociceptive response from antinociception to hyperalgesia, a phenomenon that is independent of the gender. / Em situações ameaçadoras de natureza inata ou aprendida, animais exibem um conjunto de comportamentos defensivos espécie-específicos, tais como alterações autonômicas, fuga, luta e antinocicepção. A exposição de camundongos ao labirinto em cruz elevado aberto (LCEa: quatro braços abertos), uma situação aversiva, induz antinocicepção de alta magnitude. Todavia, os mecansimos envolvidos em tal antinocicepção ainda não estão elucidados. O presente estudo investigou se a antinocicepção induzida por exposição ao LCEa: mostra tolerância cruzada a morfina (experimentos I e II); é atenuada por exposição repetida ao LCEa (experimento III); é revertida por tratamento sistêmico com naltrexona (experimento IV); é impedida por adrenalectomia (experimento V); persiste após remoção do animal do LCEa e se há diferenças relacionadas ao sexo neste fator (experimento VI); é mediada pelo receptor canabinóide, CB1 (experimento VII). Ratos foram diariamente tratados com morfina (M, 5 mg/Kg, i.p.) ou água destilada (AD) por 5 dias consecutivos (tolerância antinociceptiva avaliada pelo teste de retirada da cauda). No dia seguinte, os ratos receberam injeção de formalina 2,5% (50L) na pata traseira direita e, após a primeira fase do teste de formalina, foram tratados com M ou AD. Vinte e cinco minutos após injeção de formalina na pata, o tempo de lambidas na pata foi registrado por 10 minutos (experimento I). Procedimento semelhante foi utilizado no experimento II, exceto que o tempo de lambidas na pata foi registrado durante exposição ao LCEa ou LCE fechado (LCEf: quatro braços fechados). No experimento III, nocicepção foi avaliada em ratos submetidos a 1, 2, 3, 4 ou 6 exposições ao LCEf ou LCEa (formalina injetada somente durante a última exposição). O experimento IV investigou os efeitos de naltrexona (2,5 mg/kg; s.c.) sobre a nocicepção durante exposição ao LCEf ou LCEa. A nocicepção também foi avaliada durante exposição ao LCEf ou LCEa em ratos sham operados e adrenalectomizados (experimento V). No experimento VII, os ratos foram tratados com veículo (DMSO 60%) ou AM251 (1 mg/kg, i.p., antagonista CB1). Quinze minutos após, os animais receberam formalina na pata e, após 25 minutos, foram expostos ao LCEf ou LCEa. Já no experimento VI, ratos machos e fêmeas foram expostos ao LCEf ou LCEa, sem nenhum estímulo nociceptivo aplicado durante exposição e, imediatamente após, foram testados no teste da placa quente (52,4 °C). Os resultados mostraram que a antinocicepção induzida pelo LCEa não exibe tolerância cruzada a morfina; não foi alterada por ao menos 6 exposições ao labirinto; mostrou-se insensível à naltrexona; não foi impedida por adrenalectomia e não foi bloqueada por AM251. Ainda, tal antinocicepção não perdura após remoção dos animais do aparelho, pelo contrário, ocorre uma hiperalgesia (conforme avaliado pelo teste de placa quente), uma resposta que independe de diferenças relacionadas ao sexo. Os resultados sugerem que a antinocicepção induzida pelo LCEa: não é mediada por sistema opióide ou receptores canabinóides CB1 e não é sensível a corticosterona. Além disso, a retirada dos animais do ambiente aversivo altera a resposta nociceptiva de antinocicepção para hiperalgesia, um fenômeno que independe do gênero.

Made available in DSpace on 2014-12-17T15:37:03Z (GMT). No. of bitstreams: 1 DiegoSS_DISSERT.pdf: 636795 bytes, checksum: 620ad21d2b47550b5781855775d7f30a (MD5) Previous issue date: 2011-05-17 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / Memory and anxiety are related phenomena. Several evidences suggest that anxiety is fundamental for learnining and may facilitate or impair the memory formation process depending of the context. The majority of animal studies of anxiety and fear use only males as experimental subjects, while studies with females are rare in the literature. However, the prevalence in phobic and anxiety disorders is greater in women than in men. Moreover, it is known that gender maybe influence benzodiazepine effects, the classic drugs used for anxiety disorders treatment. In this respect, to further investigate if fear/anxiety aspects related to learning in female subjects would contribute to the study of phobic and anxiety disorders and their relationship with learning/memory processes, the present work investigates (a) the effects of benzodiazepine diazepam on female rats performance in a aversive memory task that assess concomitantly anxiety/emotionality, as the interaction between both; (b) the influence of estrous cycle phases of female rats on diazepam effects at aversive memory and anxiety/emotionality, and the interaction between both and (c) the role of hormonal fluctuations during estrous cycle phases in absence of diazepam effects in proestrus, because female rats in this phase received or not mifepristone, the antagonist of progesterone receptor, previously to the diazepam treatment. For this purpose, the plus maze discriminative avoidance task, previously validated for studies of anxiety concomitantly to learning/memory, was used. The apparatus employed is an adaptation of a conventional plus maze, with two opens arms and two closed arms, one of which presenting aversive stimulation (noise and light). The parameters used were: time in non-aversive arm compared to time in aversive and percentage of time in aversive arm on several temporal divisions, in order to evaluate memory; percentage of time in open arms, risk assessment, head dipping and end exploring to evaluate anxiety ; and distance traveled for locomotion. In experiment I, we found anxiolytic effect of diazepam only for 4 mg/kg dose, however the amnestic effect appear at a dose of 2 mg/kg. In second experiment, rats were divided in groups according estrous cycle phase (metaestrus/diestrus, proestrus e estrus). In this experiment, when we considered estrous cycle phase or diazepam treatment, the results did not demonstrate any differences in anxiety/emotionality parameters. The amnestic effects of diazepam occur in female rats in metestrus/diestrus and estrus and is absent in proestrous rats. Proestrous female rats that received mifepristone exhibited the amnestic effect of diazepam and also anxiolytic effects, that it was not previously observed in this dose. The results have demonstrated dissociation of anxiolytic and amnestic diazepam effects, not previously observed in males; the absence of amnestic effect of diazepam in proestrous phase; and the possible role of progesterone in aversive memory over diazepam effect, because the mifepristone, associated with diazepam, caused amnestic effect in proestrus / A mem?ria e a ansiedade s?o fen?menos relacionados. Diversas evid?ncias sugerem que a ansiedade ? fundamental para o aprendizado, podendo facilitar ou prejudicar a forma??o de mem?rias dependendo da situa??o, o que se constitui num fator relevante tanto para o funcionamento normal dos processos cognitivos quanto para a compreens?o dos transtornos de ansiedade. A maioria dos estudos com modelos animais que se prop?e a estudar medo e ansiedade usa machos como sujeitos experimentais existindo, assim, escassez no estudo de f?meas na literatura. Entretanto, a preval?ncia para transtornos f?bico-ansiosos ? maior em mulheres do que em homens. Al?m disso, sabe-se que o g?nero pode influenciar o efeito de benzodiazep?nicos, f?rmacos classicamente utilizados no tratamento de transtornos de ansiedade. No intuito de contribuir para o estudo de transtornos f?bico-ansiosos e sua rela??o com processos de mem?ria e aprendizado, o presente trabalho investigou (a) os efeitos do benzodiazep?nico diazepam sobre o desempenho de ratas em uma tarefa de mem?ria aversiva com concomitante avalia??o da ansiedade/emocionalidade; (b) a influ?ncia das fases do ciclo estral de ratas no efeito do diazepam na ansiedade/emocionalidade e mem?ria aversiva, assim como a intera??o entre ambas e (c) o papel de flutua??es hormonais ao longo das fases do ciclo sobre aus?ncia do efeito do diazepam no proestro, pois ratas nessa fase receberam ou n?o o antagonista do receptor da progesterona, mifepristona, previamente ao tratamento com diazepam. Para isso, foi utilizado o modelo da esquiva discriminativa em labirinto cruz elevado, previamente validado para estudos envolvendo ansiedade e aprendizagem. O aparato utilizado ? uma adapta??o do labirinto em cruz elevado convencional, constitu?do de dois bra?os abertos e dois bra?os fechados sendo que um dos fechados tem uma estimula??o aversiva com som e luz. Foram utilizados os par?metros: tempo no bra?o n?o-aversivo comparado ao tempo no aversivo e percentual de tempo no bra?o aversivo em diferentes divis?es temporais para avaliar mem?ria; percentual de tempo nos bra?os abertos, avalia??o de risco, mergulhos de cabe?a e explora??o da ponta do bra?o aberto para ansiedade ; e dist?ncia percorrida para locomo??o. A partir da curva dose-resposta, no primeiro experimento, observamos o efeito ansiol?tico (4mg/kg) e amn?stico (2mg/kg) do diazepam. No segundo experimento, as ratas foram separadas de acordo com as fases do ciclo estral (metaestro/diestro, proestro e estro). N?o foram observadas diferen?as significativas na ansiedade/emocionalidade, nem entre fases do ciclo, nem do tratamento com diazepam (2mg/kg). O efeito amn?stico do diazepam ocorreu nas ratas em metaestro/diestro e estro, estando ausente nas ratas em proestro. Na presen?a da mifepristona as ratas em proestro exibiram o efeito amn?stico do diazepam e tamb?m passaram a apresentar efeito ansiol?tico, o qual n?o havia sido observado previamente nesta dose. Os resultados demonstraram dissocia??o de efeitos amn?sticos e ansiol?ticos em f?meas, n?o previamente observada em machos; aus?ncia do efeito amn?stico do diazepam no proestro, que ocorre nas outras fases e o poss?vel papel da progesterona na mem?ria aversiva sob efeito do diazepam, uma vez que a mifepristona possibilitou o efeito amn?stico no proestro, fase na qual os n?veis de progesterona est?o elevados

Indiana University-Purdue University Indianapolis (IUPUI) / Alcoholism inheritance rates have been estimated as high as 60% in a human population. Many significant features of alcohol dependence have been replicated in rodent animal models of alcoholism, however not in totality. These animal models include inbred preferring (iP) and nonpreferring (iNP) rat types. Congenic rats have been engineered from the iP and iNP strains whereby a P congenic rat has in its genome a well-chosen chromosomal portion taken from an NP rat (P.NP) and, reciprocally, an NP congenic rat has acquired the analogous DNA from a P rat (NP.P). In this case, a quantitative trait locus (QTL) from chromosome 4 is the donor genetic material for the congenic rats. It is of great interest to further study this chromosome 4 QTL because it has been found to control a significant portion of ethanol consumption behavior in iP and iNP rats. This study aimed to behaviorally profile the iP, iNP and reciprocal congenic rats. As a result of the behavioral profiling of these genetically related groups, some conclusions could be made regarding which behaviors appear to be controlled by the chromosome 4 donor DNA.This study primarily utilized the Multivariate Concentric Square Field apparatus (MCSF) to characterize behavioral profiles for the inbred and congenic rats. The Open field (OF) and Elevated plus maze (EPM) supported this effort. The MCSF is valuable in that it allows for the animals to interact within an environment that has ethological value. The 12 different zones that make up the field are characterized by some functional quality in terms of type and duration of behavior performed, etc. The behavioral data is aggregated and finally represented in terms of five functional categories, the elements of the behavioral profile: general activity, exploratory activity, risk assessment, risk taking, and shelter seeking. The study hypotheses were shaped by prior research suggesting that iPs should display lower general activity and risk taking strategy than iNPs in the MCSF. Inbred Ps should be more active in the OF and spend more time in the center of the EPM. Generally, it is expected that the iP QTL confer behavioral phenotypes to the iNP strain that deviate toward a "P" behavioral phenotype and reciprocally, the iNP QTL confer behavioral phenotypes to the iP strain that deviate toward an "NP" behavioral phenotype. The results showed that iP rats performed more risk assessment and risk taking behavior and less shelter seeking and anxiety-like behavior than iNP rats. It followed that P.NP congenic rats significantly downgraded their risk assessment and risk taking behavior when compared to iP rats. This decrease can be attributed to the chromosome 4 QTL donated from the iNP breed. All together this study concludes that risk assessment and risk taking behavior in the iP rats is controlled by the same DNA region that, in part, determines voluntary intake of ethanol consumption. Further fine mapping of the QTL region should help in discovering if the same DNA sequences that influence ethanol intake also significantly influence risk behavior.